Nippon India Pharma Fund - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Sectoral/Thematic

Fund House : Nippon India Mutual Fund

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 523.7962 0.42%
(as on 19th September, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 8357.03 Cr

(1.67% of Investment in Category)

Expense Ratio

: 1.8%

(2.12% Category average)

Risk-O-Meter

Very High Risk

Sectoral/Thematic :Sectoral/Thematic : The fund has 99.46% investment in domestic equities of which 33.55% is in Large Cap stocks, 23.33% is in Mid Cap stocks, 11.26% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Benchmark
BSE Healthcare TRI

0%

0%

0%

0%

0%

0%

0%
NA
2.27%

5.23%

14.18%

-0.61%

18.63%

22.24%

13.03%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 19th September, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	12-Sep-25	10094.70	0.95%	-	1.37%	181/239
1 Month	19-Aug-25	10042.10	0.42%	-	2.27%	207/237
3 Month	19-Jun-25	10430.50	4.30%	-	5.23%	125/229
6 Month	19-Mar-25	10885.20	8.85%	-	14.18%	205/225
YTD	01-Jan-25	9894.70	-1.05%	-	3.97%	159/214
1 Year	19-Sep-24	10156.70	1.57%	1.57%	-0.61%	62/192
2 Year	18-Sep-23	14860.30	48.60%	21.84%	18.63%	43/151
3 Year	19-Sep-22	19196.10	91.96%	24.26%	19.20%	25/127
5 Year	18-Sep-20	22421.20	124.21%	17.50%	22.24%	80/103
10 Year	18-Sep-15	34585.00	245.85%	13.20%	14.32%	53/77
Since Inception	05-Jun-04	523796.20	5137.96%	20.42%	13.03%	38/218

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 19th September, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	19-Sep-24	12000	12497.72	4.15 %	7.75 %
2 Year	18-Sep-23	24000	27822.85	15.93 %	14.88 %
3 Year	19-Sep-22	36000	49580.35	37.72 %	21.89 %
5 Year	18-Sep-20	60000	95912.85	59.85 %	18.81 %
10 Year	18-Sep-15	120000	313832.86	161.53 %	18.27 %

SIP Calculator Detailed Returns Analysis

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 14.00% | Category average turnover ratio is 154.05%

Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)

Equity Holding : 99.46% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.46%

No of Stocks : 37 (Category Avg - 44.44) | Large Cap Investments : 33.55%| Mid Cap Investments : 23.33% | Small Cap Investments : 11.26% | Other : 31.32%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	9975.8	11.94%	-0.28%	14.41% (Sep 2024)	11.94% (Aug 2025)	62.56 L
Divis Laboratories Ltd.	Pharmaceuticals	6131.7	7.34%	-0.21%	9.65% (Nov 2024)	7.34% (Aug 2025)	10.00 L
Cipla Ltd.	Pharmaceuticals	5086.1	6.09%	0.40%	6.09% (Aug 2025)	5.32% (Dec 2024)	32.00 L
Lupin Ltd.	Pharmaceuticals	5085.9	6.09%	0.16%	8.47% (Dec 2024)	5.82% (May 2025)	26.84 L
Apollo Hospitals Enterprises Ltd.	Hospital	4937.3	5.91%	0.34%	5.91% (Aug 2025)	5.13% (Nov 2024)	6.49 L
Dr. Reddys Laboratories Ltd.	Pharmaceuticals	4934.7	5.90%	0.21%	5.9% (Aug 2025)	5.1% (Nov 2024)	39.16 L
Medplus Health Services Ltd.	Pharmacy retail	3054	3.65%	-0.21%	4.2% (May 2025)	2.35% (Sep 2024)	36.27 L
Vijaya Diagnostic Centre Ltd.	Healthcare service provider	2909.2	3.48%	-0.07%	4.09% (Nov 2024)	3.24% (May 2025)	28.87 L
GlaxoSmithKline Pharmaceuticals Ltd.	Pharmaceuticals	2543.3	3.04%	-0.27%	3.73% (May 2025)	2.02% (Jan 2025)	9.13 L
Gland Pharma Ltd.	Pharmaceuticals	2471.4	2.96%	-0.16%	3.27% (Jun 2025)	2.59% (Apr 2025)	13.21 L

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	0.41%
Net Receivables	Net Receivables	0.13%
Margin	Margin	0.00%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)

Standard Deviation
Standard Deviation value gives an idea about how volatile fund returns has been in the past 3 years. Lower value indicates more predictable performance. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A standard deviation value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

Low volatility

12.48vs14.28

Category Avg
Beta
Beta value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A beta value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

Low volatility

0.56vs0.86

Category Avg
Sharpe Ratio
Sharpe ratio indicates how much risk was taken to generate the returns. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Sharpe ratio of 1.40 and fund B has a Sharpe ratio of 1.25, you can chooses fund A, as it has given higher risk-adjusted return.

Better risk adjusted returns

1.25vs0.84

Category Avg
Treynor's Ratio
Treynor's ratio indicates how much excess return was generated for each unit of risk taken. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the beta of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Treynor's ratio of 1.40 and fund B has a Treynor's ratio of 1.25, then you can chooses fund A, as it has given higher risk-adjusted return.

Better risk adjusted returns

0.28vs0.16

Category Avg
Jensen's Alpha
Alpha indicates how fund generated additional returns compared to a benchmark. Let's say if a fund A benchmarks its returns with Nifty50 returns then alpha equal to 1.0 indicates the fund has beaten the nifty returns by 1%, so the higher the alpha, the better.

Better risk adjusted returns

11.73vs3.93

Category Avg

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth	NA	389.09	11.12	30.65	54.87	46.98	33.53
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth	NA	249.75	3.99	11.91	17.77	26.31	18.55
Franklin Asian Equity Fund - Growth	NA	259.99	5.92	13.00	16.09	18.21	12.73
Motilal Oswal Business Cycle Fund - Regular Plan - Growth	NA	1976.19	4.99	9.24	15.05	17.81	0.00
Nippon India Japan Equity Fund - Growth	NA	283.56	1.67	10.25	13.77	16.38	17.74
Nippon India US Equity Opportunities Fund - Growth	NA	713.51	3.56	7.49	10.70	15.32	19.93
Motilal Oswal Manufacturing Fund - Regular Plan - Growth	NA	786.43	7.55	9.77	22.45	11.37	0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth	NA	1533.43	6.37	21.68	34.77	11.35	0.00
HDFC Pharma and Healthcare Fund - Regular Plan - Growth	NA	1909.30	1.54	8.60	11.90	10.56	0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth	NA	8370.76	0.28	2.83	15.38	10.43	17.86

Detailed Comparison

More Funds from Nippon India Mutual Fund

Out of 129 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 9 is/are ranked 4 * , 14 is/are ranked 3 * , 7 is/are ranked 2 * , 3 is/are ranked 1 * , and 94 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Small Cap Fund - Growth	4	64821.04	1.97	4.31	16.64	-4.18	23.40
Nippon India ETF Nifty 50 BeES	4	49379.75	1.41	2.69	11.48	0.86	14.09
Nippon India ETF Nifty 50 BeES	4	49379.75	1.41	2.69	11.48	0.86	14.09
Nippon India Multicap Fund - Growth	4	46215.71	1.49	4.96	15.97	1.45	22.89
Nippon India Large Cap Fund - Growth	5	45012.18	1.99	4.85	14.21	3.57	19.99
Nippon India Growth Mid Cap Fund - Growth	4	38385.96	1.28	5.17	17.32	1.07	24.53
CPSE ETF	NA	32051.91	2.94	1.00	10.43	-3.94	35.47
CPSE ETF	NA	32051.91	2.96	1.05	10.51	-3.87	35.79
Nippon India Liquid Fund - Growth	2	30964.83	0.47	1.42	3.27	6.84	6.96
Nippon India Liquid Fund - Growth	2	30964.83	0.47	1.42	3.27	6.84	6.96